Retrieve available abstracts of 16 articles: HTML format
Single Articles
April 2025
BLUMENTHAL KG, Phillips EJ Chronic Urticaria Following HIV mRNA Vaccines: A Challenging Signal in Need of
Mechanistic Insight.
Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-25-01102. PubMed
RIDDLER SA, Moodie Z, Clark J, Yen C, et al High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505
MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial
(HVTN 302).
Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-02701. PubMedAbstract available
DACSO CC Coadministration of RSV + influenza or COVID-19 vaccines was noninferior to
separate administration for immune responses in adults aged >/=50 y.
Ann Intern Med. 2025 Apr 1. doi: 10.7326/ANNALS-25-00904. PubMedAbstract available
February 2025
IOANNOU GN, Berry K, Rajeevan N, Li Y, et al Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term
Follow-up : A Target Trial Emulation.
Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-01015. PubMedAbstract available
December 2024
VASSILOPOULOS S, Mylonakis E After COVID-19 diagnosis, risk for incident type 2 diabetes was elevated for up
to 2 y.
Ann Intern Med. 2024 Dec 3. doi: 10.7326/ANNALS-24-02887. PubMedAbstract available
November 2024
LAPRISE JF, Chesson HW, Markowitz LE, Drolet M, et al Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population
Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus
Infection in the United States.
Ann Intern Med. 2024 Nov 26. doi: 10.7326/M24-0421. PubMedAbstract available
July 2024
KAUFFMAN RP mRNA COVID-19 vaccination during pregnancy was not linked to increased adverse
neonatal outcomes.
Ann Intern Med. 2024 Jul 2. doi: 10.7326/ANNALS-24-00621. PubMedAbstract available
FUJIEDA T, Tanimoto T Communicating the Value of Influenza Vaccines to Patients.
Ann Intern Med. 2024;177:990-991. PubMed
SCHATTNER A Communicating the Value of Influenza Vaccines to Patients.
Ann Intern Med. 2024;177:990. PubMed
TENFORDE MW, Dawood FS Communicating the Value of Influenza Vaccines to Patients.
Ann Intern Med. 2024;177:991. PubMed
June 2024
DUTCHER EG, Epel ES, Mason AE, Hecht FM, et al COVID-19 Vaccine Side Effects and Long-Term Neutralizing Antibody Response : A
Prospective Cohort Study.
Ann Intern Med. 2024 Jun 11. doi: 10.7326/M23-2956. PubMedAbstract available
May 2024
Notice of Retraction: Measles, Mumps, Rubella Vaccination and Autism.
Ann Intern Med. 2024 May 21. doi: 10.7326/ANNALS-24-00530. PubMed
April 2024
COSCHI CH, Dodbiba L, Guerry D Oncology: What You May Have Missed in 2023.
Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0520. PubMedAbstract available
March 2024
WELLS CR, Pandey A, Moghadas SM, Fitzpatrick MC, et al Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination
Campaigns in the United States.
Ann Intern Med. 2024 Mar 26. doi: 10.7326/M23-2451. PubMedAbstract available
HUITS R, Grubaugh ND, Libman M, Hamer DH, et al Resurgence of Dengue in the Era of Genomic Surveillance and Vaccines.
Ann Intern Med. 2024 Mar 19. doi: 10.7326/M24-0496. PubMed
JOHANSEN ND, Vaduganathan M, Bhatt AS, Lee SG, et al Clinical Outcomes With Electronic Nudges to Increase Influenza Vaccination : A
Prespecified Analysis of a Nationwide, Pragmatic, Registry-Based, Randomized
Implementation Trial.
Ann Intern Med. 2024 Mar 19. doi: 10.7326/M23-2638. PubMedAbstract available